Atherosclerosis is one of the main causes of obliterating artery disease in 80-90% of cases

The main pathogenetic mechanism is endothelial dysfunction leading to hypertension, diabetes and congestive heart failure.

Modern society’s desire to improve the quality of life increases interest in human health in general and sexual health in particular, as erectile function is an important factor in quality of life, prompting us to seek more effective methods of diagnosis and treatment to seek and rehabilitation.

The aim of the study was to assess the efficacy of the vasoactive tripeptide Vesugen in patients with vasculogenic erectile dysfunction as a manifestation of atherosclerosis. The treatment outcomes of erectile dysfunction in 41 patients were examined.

A comparative analysis of clinical and instrumental parameters of blood flow in the main arteries of the penis before and after monotherapy was carried out.

The results show that blood flow through the main artery of the penis improved significantly both clinically and by objective indicators after treatment with Vesugen.